Ka. Krobert et al., The cloned human 5-HT7 receptor splice variants: a comparative characterization of their pharmacology, function and distribution, N-S ARCH PH, 363(6), 2001, pp. 620-632
Serotonin (5-hydroxytryptamine, 5-HT) receptor pre-mRNA is alternatively sp
liced in human tissue to produce three splice variants, h5-HT7(a), h5-HT7(b
) and h5-HT7(d), which differ only in their carboxyl terminal tails. Using
membranes from transiently and stably transfected HEK293 cells expressing t
he three recombinant h5-HT7 splice variants we compared their pharmacologic
al profiles and ability to activate adenylyl cyclase. Using PCR on cDNA der
ived from various human tissues, the 5-HT7(a) and 5-HT7(b) splice variants
were detected in every tissue examined. The h5-HT7(d) splice variant was de
tected in 13 of 16 tissues examined, with predominant expression in the hea
rt, small intestine, colon, ovary and testis. All three h5-HT7 splice varia
nts displayed high affinity binding for [H-3]5-HT (pK(d)=8.8-8.9) in the pr
esence and absence of 100 muM GTP and had similar binding affinities for al
l 17 ligands evaluated. In HEK293 cells expressing similar, high levels of
receptor (similar to 10,000 fmol/mg protein), 5-CT (5-carboxamidotryptamine
), 5-MeOT (5-methoxytryptamine) and 5-HT were full agonists while 8-OH-DPAT
((2R)-(+)8-hydroxy-2-(di-n-propylamino)tetralin) was a partial agonist wit
h relative efficacy of similar to0.8. Even at this high receptor level, EC5
0 values for stimulation of adenylyl cyclase were 10- to 50-fold higher tha
n the K-d values, indicating a lack of spare receptors. No significant diff
erences in coupling to adenylyl cyclase were observed between the three spl
ice variants over a wide range of receptor expression levels. For antagonis
ts, binding affinities determined by displacement of [H-3]5-HT binding and
by competitive inhibition of 5-HT-stimulated adenylyl cyclase activity were
essentially identical amongst the splice variants. These studies indicate
that the three human splice variants are pharmacologically indistinguishabl
e and that modifications of the carboxyl tail do not influence coupling to
adenylyl cyclase.